Dawson Geophysical (NASDAQ:DWSN) reported quarterly losses of $(0.38) per share. This is a 733.33 percent decrease over earnings of $0.06 per share from the same period last year.
Aura Biosciences Announces Interim Phase 2 Data Evaluating Suprachoroidal Administration Of Belzupacap Sarotalocan For The First-Line Treatment Of Patients With Early-Stage Choroidal Melanoma Presented At AAO 2022
Aura Biosciences Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that interim Phase 2
